However, there is limited evaluation of the impact of immunotherapeutic drugs on normal organs in patients with other cancers that express PD-L1, such as melanoma, bladder cancer and renal cell carcinoma.27 The gene discussed is CD274; the disease is hereditary clear cell renal cell carcinoma.